ArticleCurrent oncology (Toronto, Ont.)2025

Measurement of Intratumor Heterogeneity and Its Changing Pattern to Predict Response and Recurrence Risk After Neoadjuvant Chemotherapy in Breast Cancer.

Mingxi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.